| Literature DB >> 35121933 |
Eduardo Edelman Saul1, Raquel B Guerra2, Michelle Edelman Saul3, Laercio Lopes da Silva4, Gabriel F P Aleixo5, Raquel M K Matuda6, Gilberto Lopes7.
Abstract
Lung cancer accounts for an alarming human and economic burden in low- and middle-income countries (LMICs). Recent landmark trials from high-income countries (HICs) by demonstrating that low-dose computed tomography (LDCT) screening effectively reduces lung cancer mortality have engendered enthusiasm for this approach. Here we examine the effectiveness and affordability of LDCT screening from the viewpoint of LMICs. We consider resource-restricted perspectives and discuss implementation challenges and strategies to enhance the feasibility and cost-effectiveness of LDCT screening in LMICs.Entities:
Mesh:
Year: 2020 PMID: 35121933 DOI: 10.1038/s43018-020-00142-z
Source DB: PubMed Journal: Nat Cancer ISSN: 2662-1347